Regeneron Pharmaceuticals Inc. Stock Calculator

Use Regeneron Pharmaceuticals Inc. stock calculator to calculate potential returns on Regeneron Pharmaceuticals Inc. stock over time. Enter your investment amount and select a timeframe to see historical performance, total returns, and average annual growth.

Select stock to calculate:

Amount

$0$10,000

Years Ago

11y301y

If you had invested $--- in Regeneron Pharmaceuticals Inc. --- years ago, you would have $--- today

Total Return

---

Annual Return

---

Stock CFDs Ready to start trading?

Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.